{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:34:59Z","timestamp":1770971699024,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T00:00:00Z","timestamp":1402444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s13760-014-0308-9","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T17:43:09Z","timestamp":1402422189000},"page":"167-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program"],"prefix":"10.1007","volume":"114","author":[{"given":"Vincent","family":"van Pesch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Bartholom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Bissay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bouquiaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Bureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Caekebeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Debruyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Declercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dany","family":"Decoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Denayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"De Smet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"D\u2019hooghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souraya El","family":"Sankari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Geens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"van Landegem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Lysandropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain Maertens","family":"de Noordhout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Medaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Melin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelijne","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9my Phan","family":"Ba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Retif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierrette","family":"Seeldrayers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoek","family":"Symons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Urbain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Vanderdonckt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Van Ingelghem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludo","family":"Vanopdenbosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Vanroose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Van Wijmeersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Willekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiana","family":"Willems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Sindic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"issue":"9","key":"308_CR1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354(9):899\u2013910","journal-title":"N Engl J Med"},{"issue":"9","key":"308_CR2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","volume":"354","author":"RA Rudick","year":"2006","unstructured":"Rudick RA et al (2006) Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 354(9):911\u2013923","journal-title":"N Engl J Med"},{"issue":"18","key":"308_CR3","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJMoa043335","volume":"353","author":"WJ Sandborn","year":"2005","unstructured":"Sandborn WJ et al (2005) Natalizumab induction and maintenance therapy for Crohn\u2019s disease. N Engl J Med 353(18):1912\u20131925","journal-title":"N Engl J Med"},{"issue":"2","key":"308_CR4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jnnp-2011-300511","volume":"83","author":"R Phan-Ba","year":"2012","unstructured":"Phan-Ba R et al (2012) MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy. J Neurol Neurosurg Psychiatry 83(2):224\u2013226","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"308_CR5","doi-asserted-by":"crossref","unstructured":"Butzkueven H et al (2014) Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results. J Neurol Neurosurg Psychiatry. doi: 10.1136\/jnnp-2013-306936","DOI":"10.1136\/jnnp-2013-306936"},{"issue":"Suppl 3","key":"308_CR6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10072-010-0345-y","volume":"31","author":"F Piehl","year":"2011","unstructured":"Piehl F et al (2011) Swedish natalizumab (Tysabri) multiple sclerosis surveillance study. Neurol Sci 31(Suppl 3):289\u2013293","journal-title":"Neurol Sci"},{"issue":"3","key":"308_CR7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1468-1331.2008.02517.x","volume":"16","author":"AB Oturai","year":"2009","unstructured":"Oturai AB et al (2009) Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study. Eur J Neurol 16(3):420\u2013423","journal-title":"Eur J Neurol"},{"issue":"6","key":"308_CR8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00415-011-6339-8","volume":"259","author":"A Melin","year":"2012","unstructured":"Melin A et al (2012) Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis. J Neurol 259(6):1215\u20131221","journal-title":"J Neurol"},{"issue":"2","key":"308_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00415-009-5294-0","volume":"257","author":"O Outteryck","year":"2010","unstructured":"Outteryck O et al (2010) Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice. J Neurol 257(2):207\u2013211","journal-title":"J Neurol"},{"issue":"9","key":"308_CR10","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00415-012-6414-9","volume":"259","author":"O Fernandez","year":"2012","unstructured":"Fernandez O et al (2012) Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study. J Neurol 259(9):1814\u20131823","journal-title":"J Neurol"},{"issue":"3","key":"308_CR11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10072-009-0211-y","volume":"31","author":"F Sangalli","year":"2010","unstructured":"Sangalli F et al (2010) Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study. Neurol Sci 31(3):299\u2013302","journal-title":"Neurol Sci"},{"issue":"3","key":"308_CR12","first-page":"303","volume":"31","author":"L Prosperini","year":"2010","unstructured":"Prosperini L et al (2010) Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in Rome. Neurol Sci 31(3):303\u2013307","journal-title":"Neurol Sci"},{"issue":"1","key":"308_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1468-1331.2009.02728.x","volume":"17","author":"N Putzki","year":"2010","unstructured":"Putzki N et al (2010) Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. Eur J Neurol 17(1):31\u201337","journal-title":"Eur J Neurol"},{"issue":"6","key":"308_CR14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/1352458510394701","volume":"17","author":"C Holmen","year":"2011","unstructured":"Holmen C et al (2011) A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis. Mult Scler 17(6):708\u2013719","journal-title":"Mult Scler"},{"issue":"20","key":"308_CR15","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren G et al (2012) Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 366(20):1870\u20131880","journal-title":"N Engl J Med"},{"key":"308_CR16","first-page":"P04.134","volume":"78","author":"L Kappos","year":"2012","unstructured":"Kappos L et al (2012) Long-term safety and efficacy and association between baseline treatment history and postbaseline relapses in multiple sclerosis patients treated with natalizumab in the TYSABRI(R) observational program (TOP) (P04.134). Neurology 78:P04.134","journal-title":"Neurology"},{"issue":"4 suppl","key":"308_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1352458512459018","volume":"18","author":"Spelman","year":"2012","unstructured":"Spelman (2012) Comparison of natalizumab and interferon-beta\/glatiramer acetate efficacy using a propensity-matched registry data (S133). Mult Scler J 18(4 suppl):9\u201353","journal-title":"Mult Scler J"},{"issue":"3","key":"308_CR18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00415-009-0093-1","volume":"256","author":"M Hutchinson","year":"2009","unstructured":"Hutchinson M et al (2009) The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. J Neurol 256(3):405\u2013415","journal-title":"J Neurol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-014-0308-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-014-0308-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-014-0308-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T16:56:34Z","timestamp":1559494594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-014-0308-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1007\/s13760-014-0308-9","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}